Filing Details
- Accession Number:
- 0001567619-21-004324
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-17 19:31:20
- Reporting Period:
- 2021-02-14
- Accepted Time:
- 2021-02-17 19:31:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1740689 | Michael Lane | C/O Idexx Laboratories, Inc. One Idexx Drive Westbrook ME 04092 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-14 | 221 | $0.00 | 4,005 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-02-14 | 212 | $0.00 | 4,217 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-02-14 | 196 | $0.00 | 4,413 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-02-14 | 181 | $0.00 | 4,594 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-02-14 | 174 | $0.00 | 4,768 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-02-14 | 314 | $544.08 | 4,474 | No | 4 | F | Direct | |
Common Stock | Disposition | 2021-02-16 | 850 | $545.00 | 3,624 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right-to-buy) | Acquisiton | 2021-02-14 | 6,003 | $0.00 | 6,003 | $544.08 |
Common Stock | Incentive Stock Option (right-to-buy) | Acquisiton | 2021-02-14 | 183 | $0.00 | 183 | $544.08 |
Common Stock | Restricted Stock Unit | Acquisiton | 2021-02-14 | 643 | $0.00 | 643 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2021-02-14 | 221 | $0.00 | 221 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2021-02-14 | 212 | $0.00 | 212 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2021-02-14 | 196 | $0.00 | 196 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2021-02-14 | 181 | $0.00 | 181 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2021-02-14 | 174 | $0.00 | 174 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,003 | 2031-02-13 | No | 4 | A | Direct | |
183 | 2031-02-13 | No | 4 | A | Direct | |
3,292 | No | 4 | A | Direct | ||
3,071 | No | 4 | M | Direct | ||
2,859 | No | 4 | M | Direct | ||
2,663 | No | 4 | M | Direct | ||
2,482 | No | 4 | M | Direct | ||
2,308 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 592 | Indirect | by spouse |
Footnotes
- Includes 14 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2020.
- Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
- Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021.
- Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.
- Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
- Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2017.
- Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.
- Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.
- Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
- Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
- Not applicable.